Overview

DOCICAR: Cardiac Dysfunction in Cirrhosis

Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
0
Participant gender:
All
Summary
Patients with cirrhosis have a altered cardiac response to stress. This study evaluate the cardiac response by MRI during dobutamine stress. Hypothesis: impared increase in cardiac output, cardiac index, ejection fraction.
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Hvidovre University Hospital
Treatments:
Dobutamine
Criteria
Inclusion Criteria:

- Non alkoholic cirrhosis

Exclusion Criteria:

- Coma hepaticum

- Primary cardiac diseases